Contributions of radiopharmaceuticals to dosage formulation development
- At: 2006 FIP Congress in Salvadore (Brazil)
- Type: Presentation
- By: TERáN GRETTER, Mariella Adriana (Faculty of Chemistry, Radiochemistry, Montevideo, Uruguay)
Development of new drug formulations requires the performance of extensive studies, both in the laboratory, and in vivo, in animals and in volunteers. In vitro studies can be very expensive but costs are even higher when in vivo stages are reached. Methodology that can generate relevant means important savings in economic, human and time terms... The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.